Claire Le Lait earned a B.S. and M.S. degrees in Math and Computer Science (Applied Math and Statistics) from the Colorado School of Mines. She spent 5 years studying prescription drug abuse as a Biostatistician on the RADARS project at Denver Health. During the last 5 years, she has worked as a Biostatistician at Everest Clinical Research, a midsize CRO based in Canada. She has participated in phase I-IV clinical trials and is well versed in efficacy and safety analyses, CDISC standards, and SAS programming.

At Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC), Claire is serving as the Statistical Manager, and will be supporting the statistical planning and preparation for the New Drug Application (NDA) of MDMA therapy in patient with Post-Traumatic Stress Syndrome (PTSD).

Claire is enthusiastic about the potential of psychedelic therapies and is excited to be a part of a scientifically rigorous movement that brings awareness to these compounds and makes them more widely accepted and available.

In Claire’s free time, she spends her time practicing and teaching yoga, making pottery, gardening, and enjoying live music.